U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Nausea, CTCAE_3

MedGen UID:
368427
•Concept ID:
C1963179
•
Finding

Recent clinical studies

Etiology

Pretreatment with different doses of dexamethasone in the prevention of docetaxel-induced hypersensitivity.
Zhang M, Chen Z, Yang Y, Cheng H, Li C, He Q
Pak J Pharm Sci 2017 Jan;30(1):61-65. PMID: 28603114
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study.
Schöffski P, Besse B, Gauler T, de Jonge MJ, Scambia G, Santoro A, Davite C, Jannuzzo MG, Petroccione A, Delord JP
Ann Oncol 2015 Mar;26(3):598-607. Epub 2014 Dec 8 doi: 10.1093/annonc/mdu566. PMID: 25488684
A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery.
Andikyan V, Rezk Y, Einstein MH, Gualtiere G, Leitao MM Jr, Sonoda Y, Abu-Rustum NR, Barakat RR, Basch EM, Chi DS
Gynecol Oncol 2012 Nov;127(2):273-7. Epub 2012 Aug 4 doi: 10.1016/j.ygyno.2012.07.124. PMID: 22871467Free PMC Article
Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors.
Chon YE, Seong J, Kim BK, Cha J, Kim SU, Park JY, Ahn SH, Han KH, Chon CY, Shin SK, Kim DY
Int J Radiat Oncol Biol Phys 2011 Dec 1;81(5):1343-51. Epub 2010 Oct 8 doi: 10.1016/j.ijrobp.2010.07.1986. PMID: 20934268
Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
Kong L, Zhang YW, Hu CS, Guo Y
Chin J Cancer 2010 May;29(5):551-5. doi: 10.5732/cjc.009.10518. PMID: 20426907

Diagnosis

Pretreatment with different doses of dexamethasone in the prevention of docetaxel-induced hypersensitivity.
Zhang M, Chen Z, Yang Y, Cheng H, Li C, He Q
Pak J Pharm Sci 2017 Jan;30(1):61-65. PMID: 28603114
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study.
Schöffski P, Besse B, Gauler T, de Jonge MJ, Scambia G, Santoro A, Davite C, Jannuzzo MG, Petroccione A, Delord JP
Ann Oncol 2015 Mar;26(3):598-607. Epub 2014 Dec 8 doi: 10.1093/annonc/mdu566. PMID: 25488684
Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors.
Chon YE, Seong J, Kim BK, Cha J, Kim SU, Park JY, Ahn SH, Han KH, Chon CY, Shin SK, Kim DY
Int J Radiat Oncol Biol Phys 2011 Dec 1;81(5):1343-51. Epub 2010 Oct 8 doi: 10.1016/j.ijrobp.2010.07.1986. PMID: 20934268

Therapy

Pretreatment with different doses of dexamethasone in the prevention of docetaxel-induced hypersensitivity.
Zhang M, Chen Z, Yang Y, Cheng H, Li C, He Q
Pak J Pharm Sci 2017 Jan;30(1):61-65. PMID: 28603114
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study.
Schöffski P, Besse B, Gauler T, de Jonge MJ, Scambia G, Santoro A, Davite C, Jannuzzo MG, Petroccione A, Delord JP
Ann Oncol 2015 Mar;26(3):598-607. Epub 2014 Dec 8 doi: 10.1093/annonc/mdu566. PMID: 25488684
A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery.
Andikyan V, Rezk Y, Einstein MH, Gualtiere G, Leitao MM Jr, Sonoda Y, Abu-Rustum NR, Barakat RR, Basch EM, Chi DS
Gynecol Oncol 2012 Nov;127(2):273-7. Epub 2012 Aug 4 doi: 10.1016/j.ygyno.2012.07.124. PMID: 22871467Free PMC Article
Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors.
Chon YE, Seong J, Kim BK, Cha J, Kim SU, Park JY, Ahn SH, Han KH, Chon CY, Shin SK, Kim DY
Int J Radiat Oncol Biol Phys 2011 Dec 1;81(5):1343-51. Epub 2010 Oct 8 doi: 10.1016/j.ijrobp.2010.07.1986. PMID: 20934268
Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
Kong L, Zhang YW, Hu CS, Guo Y
Chin J Cancer 2010 May;29(5):551-5. doi: 10.5732/cjc.009.10518. PMID: 20426907

Prognosis

Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
Kong L, Zhang YW, Hu CS, Guo Y
Chin J Cancer 2010 May;29(5):551-5. doi: 10.5732/cjc.009.10518. PMID: 20426907

Clinical prediction guides

Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors.
Chon YE, Seong J, Kim BK, Cha J, Kim SU, Park JY, Ahn SH, Han KH, Chon CY, Shin SK, Kim DY
Int J Radiat Oncol Biol Phys 2011 Dec 1;81(5):1343-51. Epub 2010 Oct 8 doi: 10.1016/j.ijrobp.2010.07.1986. PMID: 20934268
Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
Kong L, Zhang YW, Hu CS, Guo Y
Chin J Cancer 2010 May;29(5):551-5. doi: 10.5732/cjc.009.10518. PMID: 20426907

Supplemental Content

Table of contents

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...